K. Watson

945 total citations · 1 hit paper
12 papers, 637 citations indexed

About

K. Watson is a scholar working on Rheumatology, Genetics and Pathology and Forensic Medicine. According to data from OpenAlex, K. Watson has authored 12 papers receiving a total of 637 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Rheumatology, 3 papers in Genetics and 2 papers in Pathology and Forensic Medicine. Recurrent topics in K. Watson's work include Rheumatoid Arthritis Research and Therapies (7 papers), Systemic Lupus Erythematosus Research (3 papers) and Biosimilars and Bioanalytical Methods (2 papers). K. Watson is often cited by papers focused on Rheumatoid Arthritis Research and Therapies (7 papers), Systemic Lupus Erythematosus Research (3 papers) and Biosimilars and Bioanalytical Methods (2 papers). K. Watson collaborates with scholars based in United Kingdom, United States and Germany. K. Watson's co-authors include Kimme L Hyrich, Deborah Symmons, William G Dixon, Mark Lunt, Alan J. Silman, Julia F. Simard, Martin Neovius, Joachim Listing, Elizabeth V. Arkema and A. Zink and has published in prestigious journals such as SHILAP Revista de lepidopterología, Neurology and Annals of the Rheumatic Diseases.

In The Last Decade

K. Watson

8 papers receiving 612 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Rates of serious infection, including site‐specific and bacterial intracellular infection, in rheumatoid arthritis patients receiving anti–tumor necrosis factor therapy: Results from the British Society for Rheumatology Biologics Register

2006 534 citations William G Dixon, K. Watson et al. Arthritis & Rheumatism profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
K. Watson United Kingdom	5	399	179	154	121	109	12	637
Alejandro Souto Spain	10	419 1.1×	148 0.8×	205 1.3×	116 1.0×	110 1.0×	11	660
Irena Litinsky Israel	12	372 0.9×	106 0.6×	243 1.6×	121 1.0×	92 0.8×	21	651
Júlio César Bertacini de Moraes Brazil	17	440 1.1×	156 0.9×	303 2.0×	154 1.3×	143 1.3×	49	792
Lillemor Skattum Sweden	16	196 0.5×	251 1.4×	575 3.7×	136 1.1×	97 0.9×	40	852
Beatriz Pérez-Zafrilla Spain	13	243 0.6×	105 0.6×	233 1.5×	119 1.0×	37 0.3×	17	538
Antoine Dossier France	14	201 0.5×	79 0.4×	154 1.0×	76 0.6×	68 0.6×	40	658
Neil Snowden United Kingdom	16	274 0.7×	75 0.4×	441 2.9×	168 1.4×	101 0.9×	41	919
Yoshinori Kogata Japan	8	529 1.3×	68 0.4×	98 0.6×	283 2.3×	202 1.9×	13	950
Bina Menon Malaysia	12	202 0.5×	196 1.1×	319 2.1×	39 0.3×	76 0.7×	31	727
Marije K. Verheul Netherlands	16	659 1.7×	97 0.5×	168 1.1×	41 0.3×	53 0.5×	38	900

Countries citing papers authored by K. Watson

Since Specialization

Citations

This map shows the geographic impact of K. Watson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by K. Watson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites K. Watson more than expected).

Fields of papers citing papers by K. Watson

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by K. Watson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by K. Watson. The network helps show where K. Watson may publish in the future.

Co-authorship network of co-authors of K. Watson

This figure shows the co-authorship network connecting the top 25 collaborators of K. Watson. A scholar is included among the top collaborators of K. Watson based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with K. Watson. K. Watson is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

12 of 12 papers shown

Watson, K., et al.. (2026). Sexual function and orgasm experience pre- and post-gender-affirming hysterectomies. The Journal of Sexual Medicine. 23(2).

Watson, K., et al.. (2025). Two Cases of Adhesive Arachnoiditis Following Intrathecal Nusinersen (P10-11.005). Neurology. 104(7_Supplement_1).

Watson, K., et al.. (2024). Impact of timing of delivery for type 2 diabetes on perinatal outcomes. SHILAP Revista de lepidopterología. 14. 100196–100196. 3 indexed citations

Proctor, John E., et al.. (2024). All-optical method to directly measure the pressure–volume–temperature equation of state of fluids in the diamond anvil cell. Physics of Fluids. 36(8).

Andev, Rajinder S, Lianne Kearsley‐Fleet, K. Watson, et al.. (2023). AB0411 ASSOCIATION BETWEEN ETHNICITY AND INITIAL RESPONSE TO TNF INHIBITORS IN PEOPLE WITH RHEUMATOID ARTHRITIS: RESULTS FROM THE BRITISH SOCIETY FOR RHEUMATOLOGY BIOLOGICS REGISTER FOR RHEUMATOID ARTHRITIS (BSRBR-RA). Annals of the Rheumatic Diseases. 82. 1391–1392.

Zhao, Sizheng Steven, Lianne Kearsley‐Fleet, Kimberly Rogers, et al.. (2023). POS0054 SOCIOECONOMIC DEPRIVATION IS ASSOCIATED WITH REDUCED RESPONSE AND LOWER TREATMENT PERSISTENCE WITH ANTI-TNF THERAPIES IN PEOPLE WITH RHEUMATOID ARTHRITIS. Annals of the Rheumatic Diseases. 82. 237–237. 1 indexed citations

Davies, Rebecca, et al.. (2020). SAT0103 THE EFFECT OF BODYWEIGHT ON RESPONSE TO INTRAVENOUS OR SUBCUTANEOUS TOCILIZUMAB IN PATIENTS WITH RHEUMATOID ARTHRITIS. Annals of the Rheumatic Diseases. 79. 985–985. 3 indexed citations

Jani, Meghna, William G Dixon, Mark Lunt, et al.. (2018). OP0229 The association of biologic drug-levels with infection risk: results from the british society for rheumatology biologics register for rheumatoid arthritis. Annals of the Rheumatic Diseases. 77. 163–164. 9 indexed citations

Hyrich, Kimme L, Elizabeth V. Arkema, Rebecca Davies, et al.. (2010). Detection and evaluation of a drug safety signal concerning pancreatic cancer: lessons from a joint approach of three European biologics registers. Lara D. Veeken. 50(1). 146–151. 18 indexed citations

10.

Dixon, William G, K. Watson, Mark Lunt, et al.. (2006). Rates of serious infection, including site‐specific and bacterial intracellular infection, in rheumatoid arthritis patients receiving anti–tumor necrosis factor therapy: Results from the British Society for Rheumatology Biologics Register. Arthritis & Rheumatism. 54(8). 2368–2376. 534 indexed citations breakdown →

11.

Watson, K., et al.. (2005). The British Society for Rheumatology Biologics Register. Annals of the Rheumatic Diseases. 64. iv42–iv43. 61 indexed citations

12.

Kepes, John J., et al.. (1989). Cerebellar astrocytomas in elderly patients with very long preoperative histories. Neurosurgery. 25(2). 258–258. 8 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact